Barbelo
DocSnipes
DocSnipes·August 16, 2018

Cross-Cutting Issues and Specific Mental Disorders in Co-Occurring Treatment: Suicide, Nicotine, and Personality Disorders

Watch on YouTube

Summary

This episode, part eight of SAMHSA's TIP 42, delves into the complex landscape of co-occurring disorders, focusing on critical cross-cutting issues and specific mental health conditions. DocSnipes emphasizes the necessity for mental health and substance abuse counselors to understand the interplay between various disorders, including suicidality, nicotine dependence, personality disorders, mood disorders, schizophrenia, ADHD, PTSD, eating disorders, and pathological gambling. A significant statistic highlighted is that 25-30% of ambulatory clients in general medical practices have a diagnosable psychiatric condition, underscoring the pervasive nature of comorbidity. The discussion begins with a deep dive into suicidality, identifying key risk factors such as impulsivity, hopelessness, cognitive rigidity, and substance abuse, particularly alcohol, which is associated with 25-50% of suicides.\n\nA key distinction made throughout the episode is the nuanced approach required for diagnosis, especially concerning personality disorders in clients in early recovery from addiction. DocSnipes cautions against premature diagnosis, noting that many behaviors resembling personality disorder traits (e.g., unstable relationships, unstable self-image, affective instability) can be manifestations of post-acute withdrawal syndrome (PAWS) or the learned behaviors from the addictive process itself. The episode also presents a nuanced perspective on nicotine dependence, suggesting that while it's a risk factor for relapse, for some clients in early recovery, deferring nicotine cessation might be a valid harm reduction strategy if it provides a sense of control and stability during a highly vulnerable period.\n\nPractical insights and recommendations are central to the discussion. For suicidality, clinicians are advised to screen at every client contact, assess future plans, identify specific suicide plans, understand the client's personal narrative and reasons for suicide, and explore protective factors. The importance of developing safety plans, removing means, and ensuring 24/7 crisis contact availability is stressed, alongside a strong caution against over-reliance on "no-harm contracts." For nicotine dependence, screening for tobacco use, motivation to quit, and prior attempts is crucial, with FDA-approved pharmacotherapies recommended. A critical clinical recommendation is to closely monitor the mental status of clients with serious mental illnesses who attempt to quit smoking, due to potential neurochemical shifts and changes in psychiatric medication blood plasma levels.\n\nBroader implications underscore the complexity of treating co-occurring disorders, where mental health and substance abuse issues often exacerbate each other. The episode implicitly advocates for individualized, client-centered treatment plans that prioritize immediate safety and stability while recognizing the long-term nature of recovery. It highlights the ethical imperative for thorough documentation and consistent consultation with supervisors and treatment teams, especially for high-risk clients, to ensure best practice and legal defensibility. The discussion on adolescent brain development and the prefrontal cortex further connects the clinical approach to foundational neuroscientific understanding, emphasizing the need for age-appropriate interventions and a compassionate, non-judgmental stance towards clients navigating profound personal challenges.

Key Quotes

"25 to 30 percent of ambulatory clients in general medical practices have a diagnosable psychiatric condition."
"10 to 15 percent of people suffering from major psychiatric illnesses will end their lives by suicide."
"Suicide is also more likely among those with personality traits of impulsivity, hopelessness and cognitive rigidity."
"Abuse of alcohol or drugs is a major risk factor in suicide both for people with co-occurring disorders and for the general population because using substances can sometimes be a disinhibitor."
"Asking somebody if they're thinking about committing suicide does not increase the chances that they're gonna do it."
"Don't just rely on suicide contracts or no harm contracts or whatever you call them in your place because they're really in most cases not worth the paper they're written on."
"A lot of people if they're talking about suicide the majority of people who talk about suicide are ambivalent they still have a little part of them that doesn't want to die but they also don't feel like they can continue to go on like this."
"Personality disorders... are rigid, inflexible maladaptive patterns of sufficient severity to cause internal distress or significant impairment of functioning and they're an enduring pattern that deviates markedly from the expectations of the individuals culture..."
"A lot of people who are in early recovery... are going to evidence some personality disorder like behaviors that are a result of that the addictive process."
"If they're self injuring it doesn't mean that they're necessarily going to commit suicide we do want to recognize self-injury for what it is..."
"In addiction people are often social chameleons they try to get people's approval they try to manipulate other people and they lose this their sense of self..."
"Even if the substance is technically out of their system you have that post acute withdrawal that can last again for up to a year and the person can have emotional lability for a week or two and then be symptom free."

Concepts

Themes

  • Comorbidity in mental health and addiction
  • Risk assessment and management (especially suicide)
  • Nuances of diagnosis in early recovery
  • Individualized treatment planning
  • Impact of substances on mental health and behavior
  • The role of neurobiology in addiction and mental illness
  • Clinical responsibility and documentation
  • Harm reduction strategies

Related to:

Similar Episodes